A study has confirmed the benefits of new-generation medicines, but finds they come at a cost of $10,585 for every extra year of life. The study, published this month by the US National Bureau of Economic Research, compared the average age at death from 1995 to 2008 with dates of registration of 113 drugs. It found a link, with later-version drugs, rather than older ones, associated with longer lifespans.
See all
